Zacks Small Cap Research on MSN4d
WINT: Patient Enrollment in SEISMiC C Trial Starts, Patent Position ExpandsWINT Enrolling SCAI Stage C participants in SEISMiC C trial, preparing for Phase 3 readiness Pennsylvania-based Windtree ...
Zacks Small Cap Research on MSN1mon
WINT: Lead Drug Candidates, Multiple Programs, Several Upcoming Expected MilestonesWINT is studying istaroxime for treatment of early cardiogenic shock due to heart failure. The company believes it might have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback